Form 8-K - Current report:
SEC Accession No. 0001731122-22-000565
Filing Date
2022-03-29
Accepted
2022-03-28 18:15:50
Documents
12
Period of Report
2022-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3650_8-k.htm   iXBRL 8-K 24669
  Complete submission text file 0001731122-22-000565.txt   197163

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enob-20220325.xsd EX-101.SCH 3042
3 XBRL LABEL FILE enob-20220325_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE enob-20220325_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT e3650_8-k_htm.xml XML 3621
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 22776752
SIC: 2834 Pharmaceutical Preparations